TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS financial statements, including revenue, expenses, and profit
The total revenue of 0A87 for the last quarter is 7.51 B USD, and it's 4.72% lower compared to the previous quarter. The net income of Q3 24 is 156.12 M USD.